We next evaluated the expression of TROAP target genes, such as cyclin D1, survivin, and p-AKT, because their downregulation may also be involved in the inhibition of ovarian cancer cell proliferation due to METTL14 (24–26). The gene discussed is AKT1; the disease is ovarian carcinoma.